Regulators Could Ban Holmes, Effectively Close TheranosMark Melin
A new leaked regulatory letter points to the potential to close Theranos and ban its top executives from working in the medical testing industry. The company's fate is not certain, as it could appeal a ruling or still successfully satisfy regulators.
Last week a Theranos spokesperson indicated to ValueWalk there were no issues with senior management at the company, pointing instead to issues at the Newark, CA testing facility that were being addressed. But today a March . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible